Deep resting glabellar rhytides respond to BTX-A and Hylan B

Dermatologic Surgery

Volumn 29, Issue 5, 2003, Pages 539-544

  Carruthers, Jean ^a,b   Carruthers, Alastair ^a   Maberly, David ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; HYALURONIC ACID; HYLAN B; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; FACE MALFORMATION; FEMALE; FUNCTIONAL ASSESSMENT; GLABELLAR RHYTIDES; HUMAN; INTERMETHOD COMPARISON; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; AGED; BOTULINUM TOXIN TYPE A; DRUG THERAPY, COMBINATION; FEMALE; FOREHEAD; HUMANS; HYALURONIC ACID; MIDDLE AGED; NEUROMUSCULAR AGENTS; RETROSPECTIVE STUDIES; SKIN AGING; TREATMENT OUTCOME;

EID: 0037610920     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.2003.29127.x     Document Type: Article

References (17)

1. Carruthers JA, Carruthers JDA. BOTOX treatment of glabellar frown lines and other facial wrinkles [abstract]. J Dermatol Surg Oncol 1990;10:370.
2. Carruthers JDA, Carruthers JA. The treatment of glabellar furrows with botulinum-A exotoxin. J Dermatol Surg Oncol 1992;16:83.
3. Connell BF, Lambros VS, Neurohr GR. The forehead lift: techniques to avoid complications and produce optimum results. Aesthetic Plast Surg 1989;13:217-37.
4. Connell BF. Finesse in rhytidectomy. Rec Adv Plast Surg 1985;3:137-46.
5. McCord CD Jr. Endoscopic forehead lift. In: McCord C, Codner MA, Hester TR, eds. Eyelid Surgery: Principles and Techniques. Lippincott Raven, 1995:368-79.
6. American Academy of Cosmetic Surgery Website: www.cosmeticsurgery.org. November, 2000
7. Ellis DA, Tan AK. Cosmetic upper facial rejuvenation with botulinum. J Otolaryngol 1997;26:92-6.
8. Klein AW. Cosmetic therapy with botulinum toxin. Dermatol Surg 1996;22:756-98.
9. Keen M, Blitzer A, Aviv J, et al. Botulinum toxin A for hyperkinetic facial lines: results of a double blind, placebo-controlled study. Boca Raton, FL: American Academy of Facial Plastic and Reconstructive Surgery, 1993.
10. Pribitkin EA, Greco TM, Goode RL, Keane WM. Patient selection in the treatment of glabellar wrinkles with botulinum type A injection. Arch Otolaryngol Head Neck Surg 1977;123:321-6.
11. Klein AW. In favour of double skin testing. J Dermatol Surg Oncol 1989;15:263.
12. Pollack SV. Some new injectable: dermal filler materials: hylaform, restylane, and artecoll. J Cutan Med Surg 1999; 3(Suppl 4):S27-35.
13. Frederick Brandt MD. Personal communication. Vancouver, Canada: American Academy of Cosmetic Surgery Meeting, May 2000
14. Piaquaddio DJ, Larsen NE, Denlinger JI, et al. (Hylaform) as a soft tissue augmenting material. In: Klein AW, ed. Tissue Augmentation in Clinical Practise: Procedures and Techniques. New York: Marcel Dekker, 1998:269-91.
15. Comper WD, Laurent TC. Physiological function of connective tissue polysaccharides. Physiol Rev 1978;58:255-315.
16. Poster American Academy of Dermatology Standardized photoclassification of static and dynamic glabellar rhytides developed for Phase III FDA trials to establish a cosmetic indication for glabellar BOTOX chemodenervation, Allergan Pharmaceuticals. Presented as a Poster, March 10-14, 2000. San Francisco: American Academy of Dermatology Meeting, 1999.
17. Carruthers JDA, Carruthers JA. BOTOX treatment for expressive facial lines and wrinkles: special feature. Curr Opin Otolaryngol Head Neck Surg 2000;8:357-61.